Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00636233
Other study ID # Pro00016517
Secondary ID R01NS039818
Status Completed
Phase
First received
Last updated
Start date May 1993
Est. completion date August 2, 2017

Study information

Verified date March 2019
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this research study is to discover the genetic and environmental factors that contribute to the cause of neural tube defects such as spina bifida and anencephaly. Ultimately, this type of research may result in improved diagnosis, improved treatment and possibly prevention.


Recruitment information / eligibility

Status Completed
Enrollment 10000
Est. completion date August 2, 2017
Est. primary completion date August 2, 2017
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Not currently enrolling new participants.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Duke University Medical Center Durham North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Duke University National Institute of Neurological Disorders and Stroke (NINDS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary genetic factors associated with neural tube defects This study aims to discover genetic factors associated with neural tube defects such as anencephaly. end of the study
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00031122 - Study of Genetic Risk Factors for Spina Bifida and Anencephaly N/A